Lung Cancer: Clinical and Surgical Specifications

Indexed in: Book Citation Index, Science Edition, EBSCO.

This book focuses on the lung cancer, which is the mostly encountered, and one of the most challenging malignant disease of the world. Worldwide, the annual number of new cases of lung cancer is ...
[view complete introduction]

US $
30

*(Excluding Mailing and Handling)



Immunological Approach to Lung Cancer Part B: Immunological Therapies for Lung Cancer

Pp. 455-465 (11)

Ayşegül Atak Yücel

Abstract

Lung cancer is a disease with very high morbidity and mortality rate. In spite of aggressive treatment modalities, the long- term survival is very low, and these treatments have many toxic adverse effects. Immunological therapies or briefly “immunotherapy” is a promising new therapeutic modality for lung cancer; it can be in the form of active immunization (cancer vaccines), passive immunization (adoptive cell therapy or antibody-based treatment) or immunostimulation.

Keywords:

Lung cancer, immunotherapy, vaccine, antibody-based treatment, cetuximab, bevacizumab, panitumumab, matuzumab, pertuzumab, transtuzumab, erlotinin, paclitaxel, carboplatin, gemtuzumab, GVAX, MUC1, MAGE-A3, TG4010.

Affiliation:

Gazi University, Faculty of Medicine, Department of Immunology, Beşevler, 06510 Ankara, Turkey.